• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FTC

The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024
MedTech

FTC outlines antitrust case against Edwards' JenaValve deal

In its opening statement, the FTC said Edwards would control the only two potential TAVR systems designed to treat aortic regurgitation.
Conor Hale Nov 25, 2025 3:10pm
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024

FTC tells Novo that Metsera offer may violate US merger law

Nov 5, 2025 4:26pm
Edwards Lifesciences

FTC aims to stop Edwards' acquisition of JenaValve

Aug 7, 2025 11:33am
Graphic image of the words try again on a purple background with some pixelated art below

Sanofi CEO does not rule out future Pompe BD despite FTC moves

Jan 10, 2024 3:37pm
Illumina hq

Illumina sets a date to divest Grail

Dec 18, 2023 11:12am
end of the road road block shut down closed blocked

Sanofi scraps Maze deal after FTC throws up antitrust obstacles

Dec 12, 2023 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings